Drugs · acquisition-cost intelligence
IBU
· ingredient ibuprofenAntiinflammatory preparations, non-steroids for topical use· IBUPROFEN 600 mg/1; IBUPROFEN 800 mg/1
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per EA
$0.05051
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per EA — the trend nobody else shows. 6 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other ibuprofen products, cheapest acquisition cost first. Per EA — confirm strength/form equivalence before switching.
| Product | NADAC / EA | vs this |
|---|---|---|
| basic care childrens ibuprofen | $0.03041 | −$0.02010 |
| 365 whole foods market ibuprofen | $0.03227 | −$0.01820 |
| IBU | $0.04428 | −$0.00620 |
| IBU | $0.05674 | +$0.00620 |
| Advil | $0.08009 | +$0.02960 |
| basic care childrens ibuprofen | $0.15408 | +$0.10360 |
| basic care infants ibuprofen | $0.20097 | +$0.15050 |
Medicare Part D coverage · CY2026
On 328 plan formularies · typical tier 1
Prior auth 0% · Step therapy 0% · Quantity limit 16% of formularies
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.